NEW MJ NEWS

AbbVie to Present at the 10th Annual SVB Leerink Global Healthcare Conference

 

AbbVie (NYSE: ABBV) will participate in the 10th Annual SVB Leerink Global Healthcare Conference on Friday, February 26. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 9:40 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-10th-annual-svb-leerink-global-healthcare-conference-301227093.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Neptune Wellness Solutions Inc. (NEPT) To Drive Cost Reduction by Bringing Legal Services In-House

Neptune To Drive Cost Reduction by Bringing Legal Services In-House Neptune Wellness…

Hemp, Inc. (HEMP) CEO Featured on Uptick Newswire’s Stock Day Podcast About the Growing Industrial Hemp Industry

Hemp, Inc. CEO Featured on Uptick Newswire’s Stock Day Podcast About the…

Tauriga Sciences, Inc. (TAUG) Enters into Confidential Settlement Agreement

Tauriga Sciences, Inc. Enters into Confidential Settlement Agreement and General Releases in…

Verano Holdings Corp. (VRNOF) Announces $150,000 Donation to Lynn Sage Breast Cancer Foundation

Verano Announces $150,000 Donation to Lynn Sage Breast Cancer Foundation Verano Holdings…